Preeyaporn Srasuebkul

Summary

Affiliation: University of New South Wales
Country: Australia

Publications

  1. ncbi Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment
    P Srasuebkul
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria Street, Sydney, NSW 2010, Australia
    HIV Med 8:46-54. 2007
  2. ncbi Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database
    Preeyaporn Srasuebkul
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, NSW, Australia
    Clin Infect Dis 48:940-50. 2009
  3. ncbi Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study
    Rebekah L Puls
    National Centre in HIV Epidemiology and Clinical Research, Faculty of Medicine, University of New South Wales, 45 Beach St, Coogee, New South Wales, Australia, 2034
    Clin Infect Dis 51:855-64. 2010
  4. ncbi The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy
    P Cardiello
    The HIV Netherlands Australia Thailand Research Collaborative HIVNAT, The Thai Red Cross AIDS Research Center, Bangkok, Thailand
    HIV Med 6:122-8. 2005
  5. ncbi Prior antiretroviral therapy experience protects against zidovudine-related anaemia
    S E Huffam
    National Center for HIV AIDS, Dermatology and STDs NCHADS, Ministry of Health, Phnom Penh, Cambodia
    HIV Med 8:465-71. 2007

Collaborators

Detail Information

Publications5

  1. ncbi Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment
    P Srasuebkul
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria Street, Sydney, NSW 2010, Australia
    HIV Med 8:46-54. 2007
    ..Routine CD4 count and HIV viral load monitoring is a financial barrier in developing countries...
  2. ncbi Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database
    Preeyaporn Srasuebkul
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, NSW, Australia
    Clin Infect Dis 48:940-50. 2009
    ....
  3. ncbi Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study
    Rebekah L Puls
    National Centre in HIV Epidemiology and Clinical Research, Faculty of Medicine, University of New South Wales, 45 Beach St, Coogee, New South Wales, Australia, 2034
    Clin Infect Dis 51:855-64. 2010
    ..Antiretroviral therapy is complicated by drug interactions and contraindications. Novel regimens are needed...
  4. ncbi The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy
    P Cardiello
    The HIV Netherlands Australia Thailand Research Collaborative HIVNAT, The Thai Red Cross AIDS Research Center, Bangkok, Thailand
    HIV Med 6:122-8. 2005
    ....
  5. ncbi Prior antiretroviral therapy experience protects against zidovudine-related anaemia
    S E Huffam
    National Center for HIV AIDS, Dermatology and STDs NCHADS, Ministry of Health, Phnom Penh, Cambodia
    HIV Med 8:465-71. 2007
    ....